Events & Programs

Join industry leaders, experts, and changemakers for an inspiring lineup of events within the field of NAMs. Great conversations, new insights, and powerful networking opportunities await.


ENABLE On-Site Training for bench-top simulation 

 26 November 2026, 09:30 – 16:30 | ATU Galway City Campus (Ireland)

The training was structured as a full-day programme combining introductory context, hands-on lab work, and applied strategy sessions. For participants:
  • gain an overview of STEP4NAMs and ATU's Medical & Engineering Technologies (MET) Centre
  • explore NAMs in the context of MedTech preclinical evaluation
  • set up and operate vascular in vitro test systems
  • navigate and deploy devices under real-time fluoroscopy imaging, including clot retrieval scenarios
  • work with bioplotter-based fabrication to produce anatomically relevant vascular models
  • develop 2D/planar navigation models and discuss how bench-top testing fits into regulatory development pipelines

Application Deadline: 13.11.2026

Discover moree


Science for health

Immunology reengineered: A new platform for precision medicine

 10 November 2026 |​SQUARE Brussels, Kunstberg, Brussels, Belgium

Immunology is no longer a discipline in isolation; it has become a foundational platform powering the next generation of therapies. From cell and gene therapies rewriting the rules of treatment, to antibody engineering, immune modulation and targeted immunotherapies opening new frontiers in oncology, infectious diseases and chronic inflammation, the field is redefining what medicine can achieve.

At Science for Health 2026, we explore how to fully harness this platform, accelerating its application to rare and complex diseases, and translating scientific breakthroughs into precision treatments that are as individual as the patients they serve.

Discover moree



13th Annual 3Rs Symposium: Innovative Uses for the 3Rs- Virtual + In-Person 

12. November 2026 (Virtual & In-Person) | University of Washington 3Rs Symposium - 8:00am-11:00am PT - Seattle Cancer Consortium's NAMs Symposium - 11:00am-5:00pm PT

Discover new ideas and approaches for advancing the 3Rs at this 4-day symposium. This year’s theme, Innovative Uses of the 3Rs, will bring together national and international experts to share creative solutions, emerging approaches, and practical examples of replacement, reduction, and refinement in action.

Discover moree



ENABLE On-Site Training for Organ-on-Chip technology

25. - 27. January 2027 | 3R-Center for In-vitro-Models and Alternatives to Animal Testing (Germany)

The STEP4NAMs ENABLE On-Site Training is coming to Tübingen! Are you an SME in the BioPharma or MedTech sector interested in exploring how Organ-on-Chip technology can support your R&D workflows? Mark your calendar for the first STEP4NAMs ENABLE On-Site Training at the 3R-Center for In-vitro-Models and Alternatives to Animal Testing in Tübingen, Germany. 
During this 2.5-day training, participants will gain practical insights into Organ-on-Chip technology, from microfabrication, material selection and cell seeding to fluidics, readout strategies and real-world applications.

Application Deadline: 29.11.2026

Read more


A Moonshot for NAMs

Leveraging non-animal methods to position Europe as global leader in health research

Crafting a European Moonshot Strategy for NAMs - The BioMed21 Collaboration approach

The explanatory memorandum of the draft regulation establishing Horizon Europe for the 2028-2034 period outlines plans for moonshot projects, defining them as “projects with a strong scientific component, boosting EU-wide value creation and strategic autonomy” and organised around a “coherent sequence between research and innovation, demonstration, development and deployment, focusing efforts and funding, from the EU and national, public and private sector”. The memorandum provides an indicative list of possible moonshot projects and although transitioning biomedical research to NAMs is not one of them, the Commission proposes “investing in innovative therapies for human regeneration for healthier lives and a stronger economy” and “address diseases that have currently no cure”, as well as “developing and applying the world’s next generation AI”. Such projects can only be a success if the EU also invests substantially in human-centred NAMs.

Read full Policy Paper


Advanced Innovation Challenges - Pilot

What is the EIC Advanced Innovation Challenges ?

EIC Advanced Innovation Challenges aim to support high-risk, demand-driven deep tech innovation with transformative potential especially in areas where there is extensive research but lack of commercial uptake.  

This pilot aims to assess whether competitive, stage-gated support can accelerate the path to market for high-risk deep tech innovations, and whether early integration of demand-side actors can enhance the relevance, validation, and ultimately the uptake of breakthrough solutions. The pilot will provide evidence on whether these mechanisms lead to more efficient innovation cycles and broader market adoption than other instruments within Horizon Europe. 

The EIC Advanced Innovation Challenges are shaped and steered by EIC Programme Managers, in collaboration with users and ecosystem actors, to ensure strong alignment between cutting-edge science, demand, and policy priorities.

Discover more

2026 Challenge 2: Translating Disruptive New Approach Methodologies (NAMs) into Practice

NAMs have the potential to replace, reduce or refine animal use in the testing of medicinal products. This Challenge competition therefore looks to accelerate the adoption of NAMs in biomedicine and support companies that want to bring NAMs to the market.

Watch Challenge introduction



Human-Specific Research Conference 

21 - 22 April 2027 | Crowne Plaza Newcastle

From Idea to Impact: Advancing Human-Specific Research as a Community

A new era in biomedical research is taking shape as the scientific community increasingly shifts towards research centred on human cells, human tissue, and human data. At the forefront of this shift are the scientists and groups actively pursuing the development and adoption of more effective, ethical, and human-relevant approaches. 

The Human Specific Research Conference will convene this growing interdisciplinary community to foster knowledge exchange, collaboration, and innovation across all areas of human-focused research.

​More information



4th Joint Online Workshop: Harmonisation and Standardisation of Test Methods: The Challenges of NAMs and Advanced Materials

24. - 25. November 2026 |Online

The use of New Approach Methodologies (NAMs) holds out the promise to transform chemicals and materials safety assessment by reducing reliance on animal testing and potentially lowers the costs of undertaking those tests. A wide variety of NAMs are being developed for human health and environmental protection, several of which are being supported in their development through European project funding. However, the development of NAMs and their successful uptake and acceptance by regulatory agencies is a global challenge that will require the participation of many different stakeholders. It will require policymakers around the world to accept these test results and for NAMs developers to ensure that their methods are robust and can be harmonised and accepted for regulatory testing. Due to their unique properties, Nano and advanced materials require the updating of test methods to produce the data required by regulators.  

This online workshop is brought to you by the Horizon Europe projects CHIASMA, DESIDERATA, iCare, NAMWISE, nanoPASS and RADAR, along with the Malta Initiative. It brings together researchers, regulators, industry and standards experts to help both the development of NAMs and the harmonisation and standardisation of test methods for conventional chemicals, nano and advanced materials. 

Read more


Past Events

BioMed21 Webinar: Rare Disease Research and Drug Development with NAMs in the EU

Exploring human-relevant in vitro and in silico approaches for disease modelling and therapeutic innovation 

BioMed21 (Biomedical Research for the 21st Century Collaboration) invites you to a 60-minute webinar exploring how New Approach Methodologies (NAMs), including advanced human-relevant in vitro models and in silico technologies, are transforming rare disease research and drug development.

The webinar brings together experts from academia, policy, and biomedical research to discuss innovative approaches ranging from retinal organoids and retina-on-chip systems to computational modelling and AI-driven strategies for therapy development.

Webinar recording


ENABLE On-Site Training: Your Hands-On Day at ATU Ireland 

The training was structured as a full-day programme combining introductory context, hands-on lab work, and applied strategy sessions. For participants:
  • gain an overview of STEP4NAMs and ATU's Medical & Engineering Technologies (MET) Centre
  • explore NAMs in the context of MedTech preclinical evaluation
  • set up and operate vascular in vitro test systems
  • navigate and deploy devices under real-time fluoroscopy imaging, including clot retrieval scenarios
  • work with bioplotter-based fabrication to produce anatomically relevant vascular models
  • develop 2D/planar navigation models and discuss how bench-top testing fits into regulatory development pipelines

Discover more



STEP4NAMs Webinar for ENABLE & APPLY of training programme on NAMs

During the webinar, participants will receive:

  • An introduction to the STEP4NAMs ENABLE and APPLY programmes
  • A clear overview of the available support formats for SMEs
  • Information about hands-on trainings, mentoring and technical support
  • Insights into industrial collaboration opportunities through APPLY
  • Guidance on eligibility criteria, application procedures and timelines
  • Details about the ENABLE On-Site Training at Atlantic Technological University (ATU) on 17 June 2026
  • Examples of industrial challenges and first Challenge Providers
  • Practical advice on identifying the most suitable programme format for your company
About the webinar

​


Info Webinar for the STEP4NAMs training & support programme

The STEP4NAMs project is launching a comprehensive training and support programme designed to support the uptake of New Approach Methodologies (NAMs) as alternatives to animal testing in the BioPharma and MedTech sectors.

As regulatory frameworks evolve and innovative technologies mature, the adoption of NAMs increasingly requires not only technical solutions, but also skills development, regulatory awareness and practical readiness among stakeholders. The STEP4NAMs programme addresses these needs through a structured, modular and accessible approach. 

About the webinar


​